Selegiline is a selective monoamine oxidase B (MAO-B) inhibitor used to treat Parkinson’s disease and major depressive disorder. It is administered orally or transdermally and works by increasing dopaminergic activity in the brain. The term refers to the drug, not a common noun, and its pronunciation is often the main hurdle for non-English speakers in clinical settings, research papers, and patient education materials.
"The patient was prescribed selegiline tablets to help manage motor symptoms."
"Researchers studied selegiline’s selective MAO-B inhibition to minimize side effects."
"Selegiline transdermal patches offer an alternative to oral dosing for some patients."
"In training materials, the instructor emphasized the correct pronunciation of selegiline for clarity in case notes."
Selegiline derives from a combination of morphemes reflecting its pharmacological action and discovery history. The root segment se- often signals a chemical prefix used in drug design, while -legiline mirrors the earlier compound deprenyl, indicating monoamine oxidase inhibition activity. The final -ine is a conventional chemical suffix for amines and alkaloids, signaling a nitrogen-containing compound. The drug was developed in the 1960s–1980s and marketed under brand names like Eldepryl and Zelapar, among others. The name Selegiline became the generic identifier after MAO-B selective inhibitors gained regulatory approval for Parkinson’s disease and depressive disorders. The earliest known uses appear in pharmacology literature associated with monoamine oxidase inhibitors, with explicit reference to selective MAO-B inhibition. Over time, the spelling stabilized to Selegiline, distinguishing it from non-selective MAO inhibitors and reflecting its clinical context. The etymology underlines the drug’s mechanism and its lineage from deprenyl and related compounds, while the clinical branding contributed to its widespread recognition in neurology and psychiatry. This history highlights the careful balance between chemical naming and practical pharmacology in medical discourse.
💡 Etymology tip: Understanding word origins can help you remember pronunciation patterns and recognize related words in the same language family.
Help others use "Selegiline" correctly by contributing grammar tips, common mistakes, and context guidance.
💡 These words have similar meanings to "Selegiline" and can often be used interchangeably.
🔄 These words have opposite meanings to "Selegiline" and show contrast in usage.
📚 Vocabulary tip: Learning synonyms and antonyms helps you understand nuanced differences in meaning and improves your word choice in speaking and writing.
Words that rhyme with "Selegiline"
-gin sounds
Practice with these rhyming pairs to improve your pronunciation consistency:
🎵 Rhyme tip: Practicing with rhyming words helps you master similar sound patterns and improves your overall pronunciation accuracy.
- Pronounce as seh-LEH-jih-leen in US and UK; stress on the second syllable: /ˌsɛlˈɪdʒɪˌlin/ is a common render, but more precise IPA is roughly /sɛlˈiːdʒɪliːn/ depending on accent. The most reliable approach: two explicit vowels in the first syllable with a soft 'e,' then a clear 'li' onset in the third syllable, finishing with a long 'een' sound. For practice, say: seh-LEH-jih-leen, with the primary stress on the second syllable and light, rapid secondary vowels in the remaining syllables.
Common errors: 1) Stressing the first syllable (SE-leh-gih-lean) instead of the secondary-stressed pattern; 2) Treating -gili as a hard 'g' before an 'i' (should be soft, like 'jih-'); 3) Slurring the middle vowel, producing /sɛlsɪˈdʒɪliːn/ instead of the crisp /ˌsɛlˈiːdʒɪliːn/. Correction: emphasize the second syllable with a clear 'gi' as in 'jean' but shorter, and finish with a clear long 'een.' Use slow enunciation: se-LE-gih-leen, then speed up.
In US English, you’ll hear a mid-epairstress with a slightly longer final -een; UK speakers may place a bit more emphasis on the second syllable and use a less rhotic vowel in the first syllable. Australian speakers often reduce the final vowel less aggressively and may have a more clipped middle syllable. Across accents, the key differences are vowel quality in the second and third syllables and the rhoticity that influences the presence of r-like quality in the first syllable. IPA guidance: US /səˈlɛdʒɪliːn/ or /sɛlˈɪdʒɪliːn/, UK /sɛlˈɪdʒɪliːn/, AU /sɛlˈɪdʒɪliːn/.
Two main challenges: the -legil- cluster with a soft ‘g’ makes it easy to mispronounce as 'leh-GI-lin' or 'LE-juh-lin' rather than the crisp 'le-JI-liːn.' The long final -ine can be misheard as a short -in if the tail isn’t elongated; it’s important to project the final 'een' as a long vowel. Additionally, the “se-” prefix can be mis-stressed as the primary stress, which would change rhythm. Focus on the secondary-stress pattern and the clear 'dʒɪ' sequence in the middle.
No. All letters participate in producing distinct sounds: the initial s, the 'e,' the 'l,' the 'e' before 'g,' the soft 'g' before 'i' (as in ' jean'), the 'i' in the penultimate syllable, and the final 'ne' sounding like 'een.' Some speakers may blur the trailing -ine, but the phonemic representation remains audible: /sɛlˈɪdʒɪliːn/. Always enunciate the final -leen clearly to avoid confusion with shorter endings.
🗣️ Voice search tip: These questions are optimized for voice search. Try asking your voice assistant any of these questions about "Selegiline"!
-US: rhotic, final /n/ may be less pronounced; strong /dʒ/; second syllable stress; merged vowels in rapid speech. -UK: non-rhotic; clearer separation of /dʒ/ and /ɪ/; second syllable stress with precise vowel quality. -AU: vowel quality close to UK; slightly more centralized vowels; final /liːn/ length preserved; consistent non-rhotic pattern.
No related words found
